Mark Hollywood
Director Técnico/Científico/I+D en ZYMEWORKS INC. .
Cargos activos de Mark Hollywood
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ZYMEWORKS INC. | Director Técnico/Científico/I+D | 01/01/2019 | - |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director Técnico/Científico/I+D | 30/04/2019 | - |
Historial de carrera de Mark Hollywood
Antiguos cargos conocidos de Mark Hollywood.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2010 | 01/01/2019 |
| CELLCYTE GENETICS CORPORATION | Corporate Officer/Principal | - | - |
Formación de Mark Hollywood.
| Western Illinois University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ZYMEWORKS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
CellCyte Genetics Corp.
 CellCyte Genetics Corp. Miscellaneous Commercial ServicesCommercial Services CellCyte Genetics Corp. engaged in the discovery and development of stem cell therapeutic products. It enabled therapeutic advancements to safely deliver stem cells through the patient's own circulatory or vascular system directly into a specific diseased, damaged or dying organ. The company was founded on March 9, 2004 and was headquartered in Freeland, WA. | Commercial Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Hollywood
- Experiencia
